| Financial Year |
March 31 2022 |
| Monetary Funds |
129,888,509.54 |
| Held-for-trading Financial Assets |
114,547,041.67 |
| Notes Receivable |
-- |
| Accounts Receivable |
12,541,914.45 |
| Advances to Suppliers |
120,000.00 |
| Other Receivables |
53,362,006.89 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
759,652.50 |
| Dividend Receivable |
-- |
| Inventories |
541,415.93 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
26,846.61 |
| Other Current Assets |
18,336,750.05 |
| Total Current Assets |
329,554,485.14 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
42,883.39 |
| Long-term Equity Investment |
148,692,769.30 |
| Investment Properties |
11,287,177.92 |
| Fixed Assetes |
544,757.83 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
3,329,987.62 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
6,128,230.27 |
| Deferred Income Tax Assets |
3,781.07 |
| Other Non-Current Assets |
145,086,008.08 |
| Sub-Total of Non-Current Assets |
483,356,815.49 |
| Total Assets |
812,911,300.63 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
12,242,698.07 |
| Accounts Received In Advance |
2,108,716.19 |
| Employee Compensation Payable |
3,160,121.83 |
| Taxes Payable |
23,744,491.92 |
| Interest Payable |
1,329,528.65 |
| Dividend Payable |
49,887.50 |
| Other payables |
37,787,686.70 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,476,301.74 |
| Other Current Liabilities |
8,254.72 |
| Sub-Total of Current Liabilities |
83,636,146.82 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
15,497,260.27 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
6,209,419.99 |
| Other Non-Current Liabilities |
54,736,544.00 |
| Sub-Total of Non-Current Liabilities |
77,033,864.16 |
| Total Liabilities |
160,670,010.98 |
| Paid-In Capital(Or Share Stock) |
711,132,100.00 |
| Capital Surplus |
392,777,704.41 |
| Surplus Reserve |
77,749,737.49 |
| LESS:Treasury Stock |
25,547,835.87 |
| Undistributed Profits |
-492,147,040.79 |
| Minority Stockholder's Interest |
2,692,040.92 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
649,549,248.73 |
| Owner's Equity（Stockholder's Equity） |
652,241,289.65 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
812,911,300.63 |
